Mechanistic aspects of binding of telomeric over parallel G‐quadruplex with novel synthesized Knoevenagel condensate 4‐nitrobenzylidene curcumin

Abstract

AbstractThe introduction of small ligands to stabilise G‐quadruplex DNA structures is a promising method for developing anti‐cancer drugs. It is challenging to stabilise the G‐quadruplex structure, which can take on a variety of topologies and is known to inhibit specific biological processes. To achieve this, 4‐nitrobenzylidene curcumin (NBC), the Knoevenagel condensate of curcumin, was synthesized and characterized. The interaction of 4‐nitrobenzylidene curcumin with parallel (c‐MYC) and hybrid (H‐telo) G‐quadruplex structures was studied by circular dichroism (CD) spectroscopy, UV‐thermal melting, differential scanning calorimetry (DSC), absorption spectroscopy, fluorescence spectroscopy and docking studies. The outcome demonstrates that, in a K+‐rich solution, the ligand NBC can stabilise the parallel c‐MYC and hybrid H‐telo G‐quadruplex structures by 5°C. The absorption and fluorescence studies show that the ligand NBC binds to c‐MYC and H‐telo with affinities of 0.3 × 106 M−1 and 0.6 × 106 M−1, respectively. The ligand interacts with the terminal G‐quartet of the quadruplex structure via intercalation and the groove mode of binding, well supported by docking studies as well. NBC has more potent antioxidant activity as compared to the curcumin and 4‐nitro benzaldehyde. It was also found to have higher cytotoxic activity towards cell line such as HeLa and MCF‐7, while less cytotoxic for healthy Vero cells. Overall, the results show that the Knoevenagel product of curcumin can work better as a G‐quadruplex binder and could be used as a possible treatment.